Literature DB >> 23303062

Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats.

Qin Wang1, Xiao-Fang Yue, Wei-Min Qu, Rong Tan, Ping Zheng, Yoshihiro Urade, Zhi-Li Huang.   

Abstract

Morphine is the most efficacious and widely prescribed treatment for pain. However, it decreases the total amount of deep sleep and rapid eye movement sleep in humans. Acute morphine administration at low doses causes wakefulness in animal models. To clarify the mechanism by which morphine affects sleep-wake behavior, we investigated the effects of morphine on the sleep-promoting neurons of the ventrolateral preoptic area (VLPO), a putative sleep-active nucleus, using in vitro brain slices by the patch-clamp technique. We also examined the effects of morphine on sleep-wake profiles after administration of opioid receptor antagonist to the VLPO using EEG and electromyogram recordings in freely moving rats. The results showed that morphine inhibited the firing rate of sleep-promoting neurons and hyperpolarized their membrane potentials without affecting interneurons in the VLPO. Morphine-induced hyperpolarization of membrane potentials could be reversed by, D-Phe-Cys-Thr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), a mu receptor antagonist, in the presence of tetrodotoxin. However, after the mu receptors were blocked by CTOP, morphine still suppressed the firing of the sleep-promoting neurons. This effect was antagonized by nor-BIN, a kappa receptor antagonist. Activation of kappa receptor by U50488H inhibited the firing of the sleep-promoting neurons. These results indicate that morphine could inhibit the activity of sleep-promoting neurons in the VLPO through mu and kappa receptors. EEG recordings revealed that morphine injected subcutaneously induced arousal in a dose-dependent manner. CTOP microinjected into VLPO antagonized the arousal effects of morphine, but nor-BIN did not. However, CTOP alone was not associated with any changes in the physiological sleep-wake cycle. Taken together, these findings clearly indicate that morphine inhibits sleep-promoting neurons in the VLPO by affecting mu receptors and so induces wakefulness in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23303062      PMCID: PMC3671989          DOI: 10.1038/npp.2012.244

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  41 in total

1.  Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep.

Authors:  Jun Lu; Alvhild A Bjorkum; Man Xu; Stephanie E Gaus; Priyattam J Shiromani; Clifford B Saper
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

2.  Postsynaptic mu-opioid receptor response in the median preoptic nucleus is altered by a systemic sodium challenge in rats.

Authors:  Mélaine Henry; Guy Drolet; Didier Mouginot
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

3.  Afferents to the ventrolateral preoptic nucleus.

Authors:  Thomas C Chou; Alvhild A Bjorkum; Stephanie E Gaus; Jun Lu; Thomas E Scammell; Clifford B Saper
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Identification of sleep-promoting neurons in vitro.

Authors:  T Gallopin; P Fort; E Eggermann; B Cauli; P H Luppi; J Rossier; E Audinat; M Mühlethaler; M Serafin
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep.

Authors:  J Lu; M A Greco; P Shiromani; C B Saper
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

6.  Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.

Authors:  Yi-Qun Wang; Zhi-Cai Tu; Xing-Yuan Xu; Rui Li; Wei-Min Qu; Yoshihiro Urade; Zhi-Li Huang
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

7.  Opposite modulation of histaminergic neurons by nociceptin and morphine.

Authors:  K S Eriksson; D R Stevens; H L Haas
Journal:  Neuropharmacology       Date:  2000-09       Impact factor: 5.250

8.  Arousal effect of orexin A depends on activation of the histaminergic system.

Authors:  Z L Huang; W M Qu; W D Li; T Mochizuki; N Eguchi; T Watanabe; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

9.  Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.

Authors:  Mary-Ann Greco; Patrick M Fuller; Thomas C Jhou; S Martin-Schild; James E Zadina; Zhian Hu; Priyattam Shiromani; Jun Lu
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

10.  Is morphine-induced sedation synonymous with analgesia during intravenous morphine titration?

Authors:  X Paqueron; A Lumbroso; P Mergoni; F Aubrun; O Langeron; P Coriat; B Riou
Journal:  Br J Anaesth       Date:  2002-11       Impact factor: 9.166

View more
  23 in total

1.  Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.

Authors:  Dou Yin; Yuan-Yuan Liu; Tian-Xiao Wang; Zhen-Zhen Hu; Wei-Min Qu; Jiang-Fan Chen; Neng-Neng Cheng; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

2.  Ethanol inhibits histaminergic neurons in mouse tuberomammillary nucleus slices via potentiating GABAergic transmission onto the neurons at both pre- and postsynaptic sites.

Authors:  Yu Sun; Shi-Yu Jiang; Jian Ni; Yan-Jia Luo; Chang-Rui Chen; Zong-Yuan Hong; Yuchio Yanagawa; Wei-Min Qu; Lu Wang; Zhi-Li Huang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

Review 3.  Consciousness loss during epileptogenesis: implication for VLPO-PnO circuits.

Authors:  Maohui Feng; Zhigang He; Baowen Liu; Zhixiao Li; Guorong Tao; Duozhi Wu; Hongbing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-02-15

4.  Continuous Positive Airway Pressure Mitigates Opioid-induced Worsening of Sleep-disordered Breathing Early after Bariatric Surgery.

Authors:  Sebastian Zaremba; Christina H Shin; Matthew M Hutter; Sanjana A Malviya; Stephanie D Grabitz; Teresa MacDonald; Daniel Diaz-Gil; Satya Krishna Ramachandran; Dean Hess; Atul Malhotra; Matthias Eikermann
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

5.  Adenosine A2A receptor deficiency attenuates the somnogenic effect of prostaglandin D2 in mice.

Authors:  Bin-Jia Zhang; Zhi-Li Huang; Jiang-Fan Chen; Yoshihiro Urade; Wei-Min Qu
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 7.  Fighting insomnia and battling lethargy: the yin and yang of palliative care.

Authors:  Mellar P Davis; Harold Goforth
Journal:  Curr Oncol Rep       Date:  2014-04       Impact factor: 5.075

8.  Association of preoperative sleep pattern with posthysterectomy pain: a pilot study.

Authors:  Sara Nowakowski; Melanie E Levy-Meeks; Darius B Dawson; Jessica M Meers; Jacqueline S Stout-Aguilar; Gokhan S Kilic; Mostafa A Borahay
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

9.  Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder.

Authors:  Jennifer D Ellis; Jami L Mayo; Charlene E Gamaldo; Patrick H Finan; Andrew S Huhn
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

10.  Glucose Induces Slow-Wave Sleep by Exciting the Sleep-Promoting Neurons in the Ventrolateral Preoptic Nucleus: A New Link between Sleep and Metabolism.

Authors:  Christophe Varin; Armelle Rancillac; Hélène Geoffroy; Sébastien Arthaud; Patrice Fort; Thierry Gallopin
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.